ArticleJournal of medicinal chemistry2017

Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants.

Ashley N Matthew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.